» Articles » PMID: 25430016

Partial Hepatectomy for Primary Hepatic Melanoma: a Report of Two Cases and Review of the Literature

Overview
Publisher Biomed Central
Date 2014 Nov 29
PMID 25430016
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Malignant melanoma is an extremely aggressive cancer arising from melanocytes, associated with the development of metastases in up to 20% of patients. Although the liver is a frequent metastatic site of malignant melanoma, primary hepatic melanoma (PHM) is rare. The treatment of PHM is controversial, and the prognosis for affected patients remains poor. We present two PHM patients who underwent partial hepatectomy at our institution and review the clinical and pathological data from these cases. Our results suggest that it is difficult to make a preoperative diagnosis of PHM without pathological results. For patients with resectable PHM, surgical resection is a potentially curative treatment.

Citing Articles

Report on a case of liver-originating malignant melanoma of unknown primary.

Yuan Z, Guo H, Lu W, Wang Y, He J, Zhang F Open Life Sci. 2023; 18(1):20220750.

PMID: 37941789 PMC: 10628584. DOI: 10.1515/biol-2022-0750.


[Primary liver melanoma: about a case].

Jarti M, Boulajaad S, Gouton M, Ait Errami A, Samlani Z, Oubaha S Pan Afr Med J. 2021; 40:24.

PMID: 34733392 PMC: 8531970. DOI: 10.11604/pamj.2021.40.24.29557.


Primary hepatic melanoma: A case report of computed tomography and magnetic resonance imaging findings.

Ao W, Wang J, Mao G, Yang G, Han X, Jia Y Medicine (Baltimore). 2019; 98(25):e16165.

PMID: 31232974 PMC: 6636915. DOI: 10.1097/MD.0000000000016165.


Primary Hepatic Melanoma in a Child.

Wang M, Liu H, Li Y Chin Med J (Engl). 2018; 131(17):2135-2136.

PMID: 30127232 PMC: 6111680. DOI: 10.4103/0366-6999.239318.

References
1.
Algazi A, Soon C, Daud A . Treatment of cutaneous melanoma: current approaches and future prospects. Cancer Manag Res. 2010; 2:197-211. PMC: 3004577. DOI: 10.2147/CMR.S6073. View

2.
Wolchok J, Kluger H, Callahan M, Postow M, Rizvi N, Lesokhin A . Nivolumab plus ipilimumab in advanced melanoma. N Engl J Med. 2013; 369(2):122-33. PMC: 5698004. DOI: 10.1056/NEJMoa1302369. View

3.
Houghton A, Coit D, BLOOMER W, Buzaid A, Chu D, Eisenburgh B . NCCN melanoma practice guidelines. National Comprehensive Cancer Network. Oncology (Williston Park). 1998; 12(7A):153-77. View

4.
Baab G, McBride C . Malignant melanoma: the patient with an unknown site of primary origin. Arch Surg. 1975; 110(8):896-900. DOI: 10.1001/archsurg.1975.01360140040008. View

5.
Alvarez-Downing M, Inchauste S, Dudley M, White D, Wunderlich J, Rosenberg S . Minimally invasive liver resection to obtain tumor-infiltrating lymphocytes for adoptive cell therapy in patients with metastatic melanoma. World J Surg Oncol. 2012; 10:113. PMC: 3408344. DOI: 10.1186/1477-7819-10-113. View